| Role |
Name |
Disclosure |
Details |
| Author | Benjamin Estrada, MD, Associate Professor, Department of Pediatrics and Adolescent Medicine, Division of Pediatric Infectious Diseases, University of South Alabama College of Medicine, University of South Alabama Children's and Women's Hospital | Sanofi-Pasteur | Details | | Medical Editor | Leonard R Krilov, MD, Chief of Pediatric Infectious Diseases, Vice Chair, Department of Pediatrics, Professor of Pediatrics, Winthrop University Hospital | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc | Nothing to disclose | Details | | Managing Editor | Larry I Lutwick, MD, Director, Division of Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Professor, Department of Internal Medicine, State University of New York at Downstate | Nothing to disclose | Details | | CME Editor | Robert W Tolan Jr, MD, Chief of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine | GlaxoSmithKline MedImmune MedImmune Merck Novartis sanofi pasteur sanofi pasteur sanofi pasteur Tap | Details | | Chief Editor | Michael R Bye, MD, Professor of Clinical Pediatrics, Columbia University College of Physicians and Surgeons; Acting Director, Department of Pediatric Pulmonary Medicine, Columbia University Medical Center | Merck | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Leonard R Krilov, Medical Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Larry I Lutwick, Managing Editor |
The contributor discloses no conflict of interest. |
|